NCT06003608View on ClinicalTrials.gov

Observational Small Intestine and Blood Fingerprint (SmIle) Study in Parkinson's Disease

Active, not recruitingOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

February 19, 2024

Primary Completion Date

February 28, 2025

Study Completion Date

February 28, 2025

Conditions
Parkinson Disease
Interventions
DEVICE

Fluid biopsy capsule

Ingestion of two SIMBA capsules

DRUG

Levodopa-Carbidopa Immediate Release

Single dose, Levodopa-Carbidopa Immediate Release

Trial Locations (1)

T2N 1N4

University of Calgary, Calgary

Sponsors

Collaborators (1)

MRM Health N.V.
All Listed Sponsors
collaborator

MRM Health N.V.

UNKNOWN

lead

Nimble Science Ltd.

INDUSTRY